Immucell Corp Stock
Price
Target price
€4.92
€4.92
3.800%
0.18
3.800%
-
11.12.25 / Frankfurt
WKN: 885825 / Name: ImmuCell / Stock / Biotechnology & Medical Research / Micro Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Immucell Corp Stock
Immucell Corp dominated the market today, gaining €0.18 (3.800%).
Pros and Cons of Immucell Corp in the next few years
Pros
?
M***** P*******
?
C******** o* t** e**********
?
S********** s********
Cons
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Immucell Corp vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Immucell Corp | 3.800% | 9.333% | -8.037% | 10.314% | 4.237% | -22.520% | -1.205% |
| Larimar Therapeutics Inc. | 3.660% | 8.974% | 18.056% | -40.351% | -8.602% | -5.028% | -81.027% |
| Vaxart Inc. | -0.710% | -0.639% | -0.356% | -49.821% | -58.457% | -71.193% | -95.333% |
| Achieve Life Sciences Inc. | -2.030% | -2.889% | -4.332% | -2.152% | 8.415% | 59.975% | -38.160% |
News
ImmuCell Q2 Profit Jumps as Margins Rise
ImmuCell(NASDAQ:ICCC) reported results for the three-month period ended June 30, 2025, on August 14, 2025, highlighting a sharp rebound in profitability with adjusted EBITDA of $1.43 million
ImmuCell Posts 18% Gain in Q2
ImmuCell (NASDAQ:ICCC), a specialist in animal health products for the dairy and beef industries, issued its earnings results for the second quarter of fiscal 2025 on August 14, 2025. The company